These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21501113)

  • 21. Patented pulsatile drug delivery technologies for chronotherapy.
    Patil SS; Shahiwala A
    Expert Opin Ther Pat; 2014 Aug; 24(8):845-56. PubMed ID: 24810112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thermoresponsive gating membranes embedded with liquid crystal(s) for pulsatile transdermal drug delivery: An overview and perspectives.
    Lin SY
    J Control Release; 2020 Mar; 319():450-474. PubMed ID: 31901369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chrono-drug-delivery focused on biological clock: intra- and inter-individual variability of molecular clock.
    Ohdo S
    Adv Drug Deliv Rev; 2010 Jul; 62(9-10):857-8. PubMed ID: 20553776
    [No Abstract]   [Full Text] [Related]  

  • 24. Recent technologies in pulsatile drug delivery systems.
    Jain D; Raturi R; Jain V; Bansal P; Singh R
    Biomatter; 2011; 1(1):57-65. PubMed ID: 23507727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dosing-Time Makes the Poison: Circadian Regulation and Pharmacotherapy.
    Dallmann R; Okyar A; Lévi F
    Trends Mol Med; 2016 May; 22(5):430-445. PubMed ID: 27066876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular basis of chronopharmaceutics.
    Ohdo S; Koyanagi S; Matsunaga N; Hamdan A
    J Pharm Sci; 2011 Sep; 100(9):3560-76. PubMed ID: 21656520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dosing time based on molecular mechanism of biological clock of hepatic drug metabolic enzyme].
    Matsunaga N
    Yakugaku Zasshi; 2009 Nov; 129(11):1357-65. PubMed ID: 19881208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronopharmaceutics: as a clinically relevant drug delivery system.
    Gandhi BR; Mundada AS; Gandhi PP
    Drug Deliv; 2011 Jan; 18(1):1-18. PubMed ID: 21138394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronotherapeutic Drug Delivery.
    Librodo P; Buckley M; Luk M; Bisso A
    J Infus Nurs; 2015; 38 Suppl 6():S18-23. PubMed ID: 26536406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current status and approaches to developing press-coated chronodelivery drug systems.
    Lin SY; Kawashima Y
    J Control Release; 2012 Feb; 157(3):331-53. PubMed ID: 21968338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overview of challenges and opportunities in drug delivery and pharmaceutics.
    Panicucci R; Sanchez-Felix M
    Ther Deliv; 2015; 6(8):911-4. PubMed ID: 26305510
    [No Abstract]   [Full Text] [Related]  

  • 32. [Chronopharmacology and DDS (drug delivery system)].
    Ogawa N; Ohdo S
    Nihon Rinsho; 1993 Oct; 51(10):2778-87. PubMed ID: 8254954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chrono-tailored drug delivery systems: recent advances and future directions.
    Butler CT; Rodgers AM; Curtis AM; Donnelly RF
    Drug Deliv Transl Res; 2024 Jul; 14(7):1756-1775. PubMed ID: 38416386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronopharmacokinetics of drugs in toxicological aspects: A short review for pharmacy practitioners.
    Erkekoglu P; Baydar T
    J Res Pharm Pract; 2012 Jul; 1(1):3-9. PubMed ID: 24991580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safe Nanoparticles: Are We There Yet?
    Najahi-Missaoui W; Arnold RD; Cummings BS
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Core Concept: Emerging science of chronotherapy offers big opportunities to optimize drug delivery.
    Adam D
    Proc Natl Acad Sci U S A; 2019 Oct; 116(44):21957-21959. PubMed ID: 31662491
    [No Abstract]   [Full Text] [Related]  

  • 38. The importance of chronobiology to drug discovery.
    Farrow SN; Solari R; Willson TM
    Expert Opin Drug Discov; 2012 Jul; 7(7):535-41. PubMed ID: 22657273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pharmacokinetic overview of nanotechnology-based drug delivery systems: an ADME-oriented approach.
    Hamidi M; Azadi A; Rafiei P; Ashrafi H
    Crit Rev Ther Drug Carrier Syst; 2013; 30(5):435-67. PubMed ID: 24099328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances and challenges of nanotechnology-based drug delivery systems.
    Jiang W; Kim BY; Rutka JT; Chan WC
    Expert Opin Drug Deliv; 2007 Nov; 4(6):621-33. PubMed ID: 17970665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.